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Biological context
Protein kinase (PKB), also named Akt (Staal, 1987),
is a 57–60 kDa serine/threonine protein kinase that
has emerged as a crucial regulator of widely diver-
gent cellular processes including apoptosis, prolifer-
ation, differentiation and metabolism (Nicholson and
Anderson, 2002). PKB is activated in a pathway in-
duced by the lipid products of the phosphoinositide
3-kinase (PI3K) that bind to the N-terminal Pleckstrin
Homology (PH) domain of the enzyme, thus recruit-
ing the kinase to the plasma membrane where it is
phosphorylated. It was previously shown that the PH
domain of PKB interacts also with the TCL1/MTCP1
family of proto-oncogene (the proteins p14TCL1 and
p13MTCP1, respectively), mediating the formation
of oligomeric TCL1/MTCP1-PKB high molecular
weight protein complexes in vivo (Laine et al., 2000;
Künstle et al., 2002; French et al., 2002). Within these
complexes, PKB is preferentially phosphorylated and
activated. The structures of p14TCL1 (Hoh et al., 1998),
of p13MTCP1 (Yang et al., 1998), and recently, the crys-
tal structure of the isoform PKBα-PH (Thomas et al.,
1998) have been determined. Here we report 1H, 15N
and 13C resonance assignments for PKBβ-PH (73%
homology) in the presence of Ins(1,4,5)P3, a first step
toward obtaining the solution structure as well as in-
formation on the interaction between PKB-PH and the
TCL1/MTCP1 proto-oncogenes using chemical shift
mapping studies.
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Methods and experiments
Protein expression and purification
The cDNA encoding for the 111 residues of the hu-
man PKBβ/Akt2 PH domain was sub-cloned into the
EcoRI/BamHI sites of the pGEX-2T plasmid (Amer-
sham Biosciences). The construct was transformed
for over-expression in Escherichia coli BL21 strain.
Uniform 15N and 15N/13C labelling was obtained by
growing cells in ECPM1 medium containing 15NH4Cl
and/or 13C6-glucose as the sole nitrogen and car-
bon sources. Protein expression was induced for
2 hours by addition of 0.5 mM IPTG. The cells
were then harvested by centrifugation, and the pel-
lets were sonicated in a lysis buffer. The supernatant
was applied onto a Glutathione-Sepharose (Amersham
Biosciences) column. After washing, the fusion pro-
tein was cleaved overnight at 4 ◦C by adding bovine
thrombin (Sigma Aldrich) to the beads in the low
salt buffer (50 mM Tris/HCl pH 7.4, 300 mM NaCl,
2.5 mM EDTA). The cleaved protein was further pur-
ified using size exclusion chromatography with an
Sephadex-HR100 column (Amersham Biosciences).
NMR spectroscopy
NMR samples were 0.3–0.4 mM PKBβ-PH in a buf-
fer containing 10 mM Tris/HCl pH 7.4, 300 mM
NaCl, 0.1 mM EDTA, 0.1 mM benzamidine and
4 mM Ins (1,4,5)P3 as stabilizing reagent (5% D2O
for the lock). All NMR experiments were performed
at 13 ◦C on Bruker AVANCE 500 MHz and 600 MHz
equipped with 5 mm z-gradient 1H-13C-15N. 1H chem-
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Figure 1. 1H-15N HSQC spectrum of the PKBβ PH domain re-
corded at 13 ◦C. The assignment of peaks is indicated with their
one-letter amino acid and number. Peaks belonging to the ‘minor
form’ are indicated with an asterisk.
ical shifts were directly referenced to the resonance of
cryogenic or standard probe, respectively DSS, while
13C and 15N chemical shifts were indirectly refer-
enced. The following spectra were used for the 1H,
15N, 13Cα and 13Cβ and 13CO resonance assignments:
1H-15N HSQC, HNCA, HN(CO)CA, HNCACB,
CBCA(CO)NH, HNCO, HN(CA)CO, essentially used
for sequential assignments, and H(CC)H-TOCSY,
15N- and/or 13C-edited NOESY and TOCSY exper-
iments, essentially used for side-chains assignments.
All NMR experiments were processed with Gifa (Pons
et al., 1996).
Extent of assignments and data deposition
The 1H-15N HSQC spectrum of the PKBβ PH domain
is shown in Figure 1. About 85% of the expected
backbone resonances, and 77% of the side-chain res-
onances have been assigned. Sequential assignment
failed for two segments (Glu59-Gln61 and Arg76-
Thr87: ≈ 15% of the backbone resonances) linked by
a disulfide bond (Cys60-Cys77), probably due to local
conformational exchange on an intermediate timescale
arising from the bridge isomerization. In addition, the
residues belonging to the segment Pro42-Pro51 exhib-
ited ‘minor form’ peaks, ranging in intensity from
15–25% of the ‘major form’ peak. Potential sources
for the minor peaks presumably involve proline iso-
merization states (4 proline residues in this segment),
and modification of aromatic ring current effects in
the close neighbourhood of this peptidic segment.
The chemical shifts of the PKBβ PH domain (major
conformation) have been deposited in the BioMagRes-
Bank under the accession number BMRB-5778. A full
3D structure determination is in progress.
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